Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|
| Total reported revenue | 1.3T | 1.3T | 1.3T |
| Cost of revenue | 1.1T | 1.1T | 1.1T |
| Gross profit | 165.4B | 168.7B | 170.0B |
| Operating expense | |||
| Research & development | — | — | — |
| Selling general and admin | 116.4B | 100.4B | 95.7B |
| Other operating expenses | 22.0B | 14.9B | 13.7B |
| Operating income | 41.6B | 62.8B | 70.6B |
| Non operating interest income | |||
| Income | 1.4B | 990M | 1.8B |
| Expense | 5.8B | 6.3B | 5.9B |
| Other income expense | — | — | — |
| Pretax income | 42.0B | 71.0B | 75.5B |
| Tax provision | 6.7B | 17.0B | 23.5B |
| Net income | 35.3B | 54.0B | 52.0B |
| Basic EPS | — | 83.1 | 84.9 |
| Diluted EPS | — | 79.4 | 83.8 |
| Basic average shares | — | 636.0M | 594.7M |
| Diluted average shares | — | 665.0M | 602.5M |
| EBITDA | 120.8B | 146.1B | 155.0B |
| Net income from continuing op. | 42.0B | 71.0B | 75.5B |
| Minority interests | -809M | -1.2B | -1.5B |
| Preferred stock dividends | -1M | 0 | 1M |